JPRN-UMIN000017700尚未招募未知
The retrospective study on elderly colon cancer patient about the change of the treatment and prognostic relationship. - The retrospective study on elderly colon cancer patient
Department of Coloproctological Surgery, Juntendo University, Faculty of Medicine0 个研究点目标入组 300 人开始时间: 2015年5月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 70years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 The case that it faced each other other than a target disease, and an operation was carried out 2 In addition, the case that a study person in charge judged to be inappropriate as a subject
研究者
相似试验
招募中
不适用
COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of life10017991colorectal cancerNL-OMON32845Wageningen Universiteit1,000
招募中
Unknown
Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR studycolorectal cancerJPRN-UMIN000051316Kyoto Prefectural University of Medicine1,000
进行中（未招募）
不适用
Colorectal cancer cohort study (COLO-COHORT)Colorectal neoplasia, colorectal cancerColorectal neoplasiaCancerISRCTN17473023South Tyneside and Sunderland NHS Foundation Trust15,000
进行中（未招募）
1 期
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
已完成
不适用
Colomid: Midkine as a predictive marker in colorectal cancerACTRN12613000111774Calvary Mater Newcastle Hospital33